Arrivent Biopharma, Inc.
AVBP
Revenue
0.00
0.000.00%
-Assets
333.17M
▲6.61M▲2.03%
3 Months ChangeLiabilities
25.95M
▲4.39M▲20.35%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-05
Form 8-K
ID: 0001104659-26-024112
2025-11-10
Form 10-Q
ID: 0001104659-25-108847
2025-11-10
Form 8-K
ID: 0001104659-25-108839
2025-09-09
Form 8-K
ID: 0001558370-25-011954
2025-08-11
Form 10-Q
ID: 0001558370-25-010975
2025-08-11
Form 8-K
ID: 0001558370-25-010974
2025-07-21
Form 8-K
ID: 0001104659-25-069169
2025-07-02
Form 8-K
ID: 0001104659-25-065386
2025-06-23
Form 8-K
ID: 0001104659-25-061375
2025-06-20
Form 8-K
ID: 0001104659-25-061165